245 related articles for article (PubMed ID: 22453011)
1. Molecular testing in melanoma.
Wilson MA; Nathanson KL
Cancer J; 2012; 18(2):117-23. PubMed ID: 22453011
[TBL] [Abstract][Full Text] [Related]
2. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
[TBL] [Abstract][Full Text] [Related]
4. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
Lovly CM; Dahlman KB; Fohn LE; Su Z; Dias-Santagata D; Hicks DJ; Hucks D; Berry E; Terry C; Duke M; Su Y; Sobolik-Delmaire T; Richmond A; Kelley MC; Vnencak-Jones CL; Iafrate AJ; Sosman J; Pao W
PLoS One; 2012; 7(4):e35309. PubMed ID: 22536370
[TBL] [Abstract][Full Text] [Related]
5. Impact of genomics on the surgical management of melanoma.
Ferguson PM; Long GV; Scolyer RA; Thompson JF
Br J Surg; 2018 Jan; 105(2):e31-e47. PubMed ID: 29341162
[TBL] [Abstract][Full Text] [Related]
6. Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.
Delaunay J; Martin L; Bressac-de Paillerets B; Duru G; Ingster O; Thomas L
JAMA Dermatol; 2017 Nov; 153(11):1122-1129. PubMed ID: 28903138
[TBL] [Abstract][Full Text] [Related]
7. Frontline approach to metastatic BRAF-mutant melanoma diagnosis, molecular evaluation, and treatment choice.
Chapman PB; Hauschild A; Sondak VK
Am Soc Clin Oncol Educ Book; 2014; ():e412-21. PubMed ID: 24857132
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
9. Clinical implications of cytogenetic abnormalities in melanoma.
Nelson MA; Thompson FH; Emerson J; Aickin M; Adair L; Trent JM; Leong SP; Taetle R
Surg Clin North Am; 1996 Dec; 76(6):1257-71. PubMed ID: 8977549
[TBL] [Abstract][Full Text] [Related]
10. [Personalized therapy concepts for malignant melanoma].
Schlaak M; Kreuzberg N; Mauch C; Kurschat P
Internist (Berl); 2013 Feb; 54(2):188-93. PubMed ID: 23371260
[TBL] [Abstract][Full Text] [Related]
11. Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma.
Olszanski AJ
J Natl Compr Canc Netw; 2019 May; 17(5.5):615-617. PubMed ID: 31117032
[TBL] [Abstract][Full Text] [Related]
12. [Genetic factors in the development and progression of malignant melanoma].
Rünger TM; Bröcker EB
Hautarzt; 1995 Jun; 46(6):394-9. PubMed ID: 7642382
[TBL] [Abstract][Full Text] [Related]
13. Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ; Jaju PD; Tang JY; Carbone M; Leachman S; Sarin KY
J Am Acad Dermatol; 2016 Mar; 74(3):423-34; quiz 435-6. PubMed ID: 26892652
[TBL] [Abstract][Full Text] [Related]
14. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
15. [Molecular diagnostics of melanomas].
Griewank KG
Pathologe; 2015 Feb; 36(1):30-6. PubMed ID: 25491471
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnostics in melanoma].
Lang R; Bauer JW; Laimer M
Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic analysis of melanomas arising in acral sites.
Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
[TBL] [Abstract][Full Text] [Related]
18. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach.
Bradish JR; Cheng L
Hum Pathol; 2014 Jul; 45(7):1315-26. PubMed ID: 24856851
[TBL] [Abstract][Full Text] [Related]
20. Molecular testing in malignant melanoma.
Grossmann AH; Grossmann KF; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
